SRX17984428 GSM6665414_r1 SRP403910 PRJNA892905 SRS15498918 GSM6665414 GSM6665414 OTHER GENOMIC other Unbiased chromatin-affinity assay was performed according to the published protocol with modification (Mumbach et al., 2019). A total of 100 million preadipocytes (pre-treated with GW1929 for 24 hours) were used for each replicate and 2 replicates were performed for each group. For negative control, RNase A and RNase H were added as the amount of 2 μg per million cells. Libraries were paired-end sequenced by NovaSeq S4 with read lengths of 150bp Illumina NovaSeq 6000 SRX17984429 GSM6665415_r1 SRP403910 PRJNA892905 SRS15498919 GSM6665415 GSM6665415 OTHER GENOMIC other Unbiased chromatin-affinity assay was performed according to the published protocol with modification (Mumbach et al., 2019). A total of 100 million preadipocytes (pre-treated with GW1929 for 24 hours) were used for each replicate and 2 replicates were performed for each group. For negative control, RNase A and RNase H were added as the amount of 2 μg per million cells. Libraries were paired-end sequenced by NovaSeq S4 with read lengths of 150bp Illumina NovaSeq 6000 SRX17984430 GSM6665416_r1 SRP403910 PRJNA892905 SRS15498920 GSM6665416 GSM6665416 OTHER GENOMIC other Unbiased chromatin-affinity assay was performed according to the published protocol with modification (Mumbach et al., 2019). A total of 100 million preadipocytes (pre-treated with GW1929 for 24 hours) were used for each replicate and 2 replicates were performed for each group. For negative control, RNase A and RNase H were added as the amount of 2 μg per million cells. Libraries were paired-end sequenced by NovaSeq S4 with read lengths of 150bp Illumina NovaSeq 6000 SRX17984431 GSM6665417_r1 SRP403910 PRJNA892905 SRS15498921 GSM6665417 GSM6665417 OTHER GENOMIC other Unbiased chromatin-affinity assay was performed according to the published protocol with modification (Mumbach et al., 2019). A total of 100 million preadipocytes (pre-treated with GW1929 for 24 hours) were used for each replicate and 2 replicates were performed for each group. For negative control, RNase A and RNase H were added as the amount of 2 μg per million cells. Libraries were paired-end sequenced by NovaSeq S4 with read lengths of 150bp Illumina NovaSeq 6000 SRX17984432 GSM6665418_r1 SRP403910 PRJNA892905 SRS15498922 GSM6665418 GSM6665418 OTHER GENOMIC other Unbiased chromatin-affinity assay was performed according to the published protocol with modification (Mumbach et al., 2019). A total of 100 million preadipocytes (pre-treated with GW1929 for 24 hours) were used for each replicate and 2 replicates were performed for each group. For negative control, RNase A and RNase H were added as the amount of 2 μg per million cells. Libraries were paired-end sequenced by NovaSeq S4 with read lengths of 150bp Illumina NovaSeq 6000 SRX17984433 GSM6665419_r1 SRP403910 PRJNA892905 SRS15498923 GSM6665419 GSM6665419 OTHER GENOMIC other Unbiased chromatin-affinity assay was performed according to the published protocol with modification (Mumbach et al., 2019). A total of 100 million preadipocytes (pre-treated with GW1929 for 24 hours) were used for each replicate and 2 replicates were performed for each group. For negative control, RNase A and RNase H were added as the amount of 2 μg per million cells. Libraries were paired-end sequenced by NovaSeq S4 with read lengths of 150bp Illumina NovaSeq 6000